[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100524183":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":7,"centralContacts":13,"locations":22,"responsibleParty":41,"collaborators":7,"id":43,"slug":44,"hasResults":45,"nctId":46,"briefTitle":47,"officialTitle":47,"acronym":48,"eligibilityCriteria":49,"healthyVolunteers":45,"sex":50,"minAge":51,"maxAge":7,"enrollmentInfo":52,"targetDuration":7,"studyType":55,"phases":7,"briefSummary":56,"conditions":57,"keywords":59,"overallStatus":25,"whyStopped":7,"lastUpdateSubmitDate":64,"lastUpdatePostDateStruct":65,"startDateStruct":68,"completionDateStruct":70,"leadSponsor":72,"locationsCount":73},{"fullName":5,"class":6},"Peter MacCallum Cancer Centre, Australia","OTHER",null,[9],{"type":10,"name":11,"description":12,"armGroupLabels":7,"otherNames":7},"DIAGNOSTIC_TEST","68Ga-labelled TAFC PET\u002FCT scan","68Ga-labelled TAFC PET\u002FCT scan (whole body)",[14,19],{"name":15,"role":16,"phone":17,"phoneExt":7,"email":18},"Abby Douglas","CONTACT","03 855 96136","Abby.Douglas@petermac.org",{"name":20,"role":16,"phone":7,"phoneExt":7,"email":21},"Beatrice Sim","Beatrice.Sim@petermac.org",[23],{"facility":24,"status":25,"city":26,"state":27,"zip":28,"country":29,"countryCode":30,"cosmosGeoPoint":31,"geoPoint":36,"contacts":37},"Peter MacCallum Cancer Centre","RECRUITING","Melbourne","Victoria","3000","Australia","AU",{"type":32,"coordinates":33},"Point",[34,35],144.96332,-37.814,{"lat":35,"lon":34},[38,40],{"name":15,"role":16,"phone":39,"phoneExt":7,"email":18},"855 96136",{"name":20,"role":16,"phone":7,"phoneExt":7,"email":21},{"type":42,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100524183","siderophore-labelled-positron-emission-tomography-for-correlating-invasive-fungal-infections-100524183",false,"NCT06105411","Siderophore-labelled Positron Emission Tomography for Correlating Invasive Fungal InfeCtions","SPECIFIC","Inclusion Criteria:\n\n1. Patient has provided written informed consent\n2. Aged 18 years or older at written informed consent\n3. Within 2 weeks of proven or probable or possible invasive fungal infection (IFI) diagnosis as per EORTC criteria\n4. Imaging consistent with invasive pulmonary aspergillosis on CT or FDG-PET\u002FCT with lesions at least 8mm in diameter\n5. Patient is willing and able to comply with the protocol for the duration of the study including scheduled visits such as follow up\n\nExclusion Criteria:\n\n1. Women who are pregnant or lactating.\n2. Iron infusion within one week prior to scan","ALL","18 Years",{"count":53,"type":54},10,"ESTIMATED","OBSERVATIONAL","This trial will demonstrate localised uptake of a radiolabelled fungal component (siderophore) in areas of known specific invasive fungal (Aspergillus) infection.",[58],"Invasive Fungal Infections",[58,60,61,62,11,63],"Siderophore","PET","Siderophore-labelled Position Emission tomography","Aspergillus spp.","2025-08-28",{"date":66,"type":67},"2025-09-05","ACTUAL",{"date":69,"type":67},"2023-12-01",{"date":71,"type":54},"2027-04",{"name":5,"class":6},1]